ORT-B.ST Ortoma AB Series B

Healthcare Medical Devices Stockholm Exchange
10.97 SEK
Close of Nov 7, 2026
6.81 16.95
Market cap
SEK 495M
P/E
-
P/B
2.69x
ROE
-33.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is ORT-B.ST undervalued?

Graham number

The Graham number of Ortoma AB Series B cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ortoma AB Series B fundamental analysis

No fundamental analysis for Ortoma AB Series B yet.

Ortoma AB Series B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ortoma AB Series B

Ortoma AB (publ), a medical technology company, focuses on Al-based technology for orthopedic surgical procedures in Sweden. It offers Ortoma Treatment Solution (OTS), a server-based AI integrated orthopedic platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up; and O…

Full company profile